Unraveling How A Drug Helps Patients With Multiple Sclerosis
Main Category: Multiple SclerosisAlso Included In: Biology / Biochemistry; Immune System / Vaccines
Article Date: 02 Apr 2008 - 4:00 PDT
| Patient / Public: | ![]() |
3.29 (7 votes) |
| Health Professional: | ![]() |
|
| Article Opinions: | 0 posts |
Although the drug IFN-beta is commonly used to treat individuals with the relapsing-remitting form of multiple sclerosis (MS), little is known about the mechanism(s) by which it acts. However, Genhong Cheng and colleagues, at the University of California at Los Angeles, have now reported a mechanistic pathway by which it reduces disease in a mouse model of MS known as EAE.
In addition to being a drug, IFN-beta is produced naturally by the body during certain immune responses. In the study, mice lacking a component of the molecule to which IFN-beta binds to mediate its effects were found to develop more severe EAE than mice expressing this protein. This was associated with increased numbers of immune cells known as Th17 cells in the central nervous system of the mice, the part of the body affected in individuals with MS. Further experiments showed that disease could be alleviated in these mice by administration of a soluble molecule known as IL-27, leading the authors to suggest that in individuals with MS, the beneficial effects of IFN-beta are likely to be mediated, at least in part, through its ability to induce the secretion of IL-27.
----------------------------
Article adapted by Medical News Today from original press release.
----------------------------
TITLE: The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
AUTHOR CONTACT:
Genhong Cheng
University of California at Los Angeles, Los Angeles, California, USA.
Source: Karen Honey
Journal of Clinical Investigation
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |





